Sort   by:  
 Page size 
MetabolomicsMetabolome of ginsenoside anti-tumor
Not available
ORGANISM(S): Homo sapiens 
ST001191 | MetabolomicsWorkbench
MetabolomicsLow-Protein Diet Enhances Anti-Tumor Immunity in Pancreatic Cancer through Microbiota-Derived Uridine Diphosphate-Galactose
Low-protein diets (LPD) have been linked to improved metabolic health, but their role in pancreatic ductal adenocarcinoma (PDAC) immunotherapy remains unclear. Here we show that an LPD suppresses PDAC progression in male mice by remodeling the gut microbiota and activating anti-tumor immunity. LPD p...
2026-07-09 | MTBLS14989 | MetaboLights
MetabolomicsUtilizing Metabolomics to Understand Novel Anti-Desmoid Tumor Drugs (part II)
Not available
ORGANISM(S): Homo sapiens 
ST000455 | MetabolomicsWorkbench
MetabolomicsUtilizing Metabolomics to Understand Novel Anti-Desmoid Tumor Drugs (part I)
Not available
ORGANISM(S): Homo sapiens 
ST000454 | MetabolomicsWorkbench
MetabolomicsPharmacological Targeting of ALDH1a2 in Dendritic Cells Enhances Antigen Presentation, T Cell Activation and Anti-tumor immunity
Dendritic cell (DC) vaccines have been proposed as cancer immunotherapies due to their role as crucial antigen-presenting cells that regulate T cell functions. Despite considerable efforts to optimize ex vivo priming of DCs, DC vaccines have rarely been successful, suggesting the presence of unknown...
2025-11-03 | MTBLS10389 | MetaboLights
MetabolomicsPreoperative exercise induces anti-tumor Kupffer cells to prevent surgical stress-promoted colorectal cancer liver metastasis

Kupffer cells from both Sed and PEx mice were harvested for Metabolomics. 3 weeks after tumor injection, both mice bearing MC38 tumors were sacrificed. The livers were harvested and processed into single-cell suspensions, and KCs were isolated.

2025-12-09 | MTBLS13419 | MetaboLights
MetabolomicsMouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment
Not available
ORGANISM(S): Mus musculus 
ST001611 | MetabolomicsWorkbench
ModelsYazdjer2019 - reinforcement learning-based control of tumor growth under anti-angiogenic therapy
This model is based on: Reinforcement learning-based control of tumor growth under anti-angiogenic therapy Authors: Parisa Yazdjerdi, Nader Meskin, Mohammad Al-Naemi, Ala-Eddin Al Moustafa, Levente Kovacs Abstract: Background and objectives: In recent decades, cancer has become one of the most fata...
2024-09-02 | BIOMD0000000821 | BioModels
ModelsBoer1985 - Macrophage T cell interaction in anti-tumor response
In this paper we present a model of the macrophage T lymphocyte interactions that generate an anti-tumor immune response. The modseple cifies i) induction of cytotoxic T lymphocytes, ii) antigen presentation by macrophages, which leads to iii) activation of helper T cells, and iv) production of lymp...
2019-11-13 | MODEL1911130003 | BioModels
Immuno-oncology 
ProteomicsMulti-omics Study Reveals the Synergistic Anti-tumor Effects of Aspirin and Gemcitabine-based Chemotherapy on Pancreatic Cancer and the Underlying Mechanism
Pancreatic cancer is a highly malignant tumor that is well known for its poor prognosis. It has been reported that aspirin can reduce the risk of various cancers, but the potential role of aspirin and gemcitabine in pancreatic cancer pathogenesis and chemotherapy has not been studied. Therefore, we ...
ORGANISM(S): Homo sapiens (Human) 
2022-05-31 | PXD031910 | Pride
Pancreatic cancer Multi-omics Synergistic effect Aspirin Gemcitabine 
Sort   by:  
 Page size